Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd.
Clinical trials sponsored by Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug 608 aims to ease back pain in ankylosing spondylitis Results expected Jan 2027 (estimated)
- New asthma drug shows promise in late-stage trial Results expected Feb 2027 (estimated)
- New drug 610 aims to tame severe asthma attacks Results expected Feb 2027 (estimated)
- New antibody injection could stop gout flares while lowering uric acid Results expected Aug 2027 (estimated)
- New injection aims to tame tough eczema Results expected Aug 2027 (estimated)
-
Can a new injection calm severe eczema in kids?
Disease control Not yet recruitingThis trial is testing an experimental drug called 611 in children aged 2 to 12 with moderate-to-severe atopic dermatitis, a common skin condition that causes itchy, inflamed skin. The drug is designed to block a specific immune signal that drives the inflammation behind eczema. T…
Phase 3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New antibody injection could stop gout flares while lowering uric acid
Disease control Not yet recruitingThis study tests an experimental drug called SSGJ-613, a lab-made antibody, to prevent sudden gout attacks in people who are starting medication to lower uric acid. About 200 adults with frequent gout flares will receive either SSGJ-613 injections or standard colchicine pills for…
Phase 2 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug 608 aims to ease hidden arthritis pain
Disease control Not yet recruitingThis study tests a drug called 608 in 380 adults with non-radiographic axial spondyloarthritis, a form of arthritis that causes back pain and stiffness but doesn't show up on X-rays. Participants will receive either 608 or a placebo injection to see if the drug reduces pain and i…
Phase 3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC